Patient number | Age, sex (years; female or male) | Abatacept dose (mg); duration of exposurea (months) | Number of vaccine injections | Duration between last vaccination and abatacept initiation (months) | Duration between last vaccination and antibody sample collection (months) | Blood antibody level to diphtheriab (IU/mL) | Blood antibody level to tetanusb (IU/mL) | Concomitant MTX dosec (mg/m2/week; oral or SC) | Concomitant prednisone dosec (mg/kg/day) |
---|---|---|---|---|---|---|---|---|---|
1 | 5, F | 50; 27 | N/A | N/A | N/A | 0.6 | 5.4 | – | – |
2 | 3, F | 50; 19 | 4 | 30 | 49 | 0.8 | 0.4 | 7.9, O | – |
3 | 3, M | 50; 4 | 4 | 27 | 30 | 0.2 | 0.8 | 16.6, O | – |
4 | 5, F | 50; 24 | 4 | −3 | 21d | 0.8 | 2.2 | 15.5, O | – |
5 | 5, F | 50; 22 | 5 | N/A | N/A | 0.5 | 4.9 | 3.4, O | – |
6 | 5, F | 50; 22 | 4 | 52 | 73 | 0.9 | 1.0 | 9.9, O | – |
7 | 4, M | 87.5e; 19 | 4 | 47 | 66 | 0.5 | 5.9 | – | – |
8 | 4, M | 50; 19 | 5 | 43 | 62 | 0.7 | 8.2 | 13.1, SC | – |
9 | 4, F | 50; 16 | 3 | 52 | 67 | 0.5 | 0.6 | 16.2, SCf | – |
10 | 5, M | 50; 19 | 5 | 54 | 72 | 0.7 | 8.3 | 16.0, SC | – |
11 | 3, F | 50; 19 | 4 | 36 | 54 | 0.5 | 0.4 | – | – |
12 | 4, M | 87.5; 4 | 4 | 35 | 39 | 0.4 | 2.3 | 14.0, O | – |
13 | 3, F | 50; 4 | 4 | 30 | 34 | 0.6 | 2.0 | 11.7, SC | – |
14 | 4, F | 50; 2 | 4 | 46 | 48 | 0.5 | 1.8 | 10.4, SC | – |
15 | 2, F | 50; 2 | 3 | 24 | 26 | 0.6 | 3.1 | 14.3, SC | – |
16 | 5, M | 50; 3 | 4 | 57 | 60 | 0.4 | 0.6 | – | – |
17 | 5, M | 87.5; 3 | 4 | 57 | 60 | 0.3 | 1.1 | – | – |
18 | 2, F | 50; 3 | 4 | 21 | 24 | 0.1 | 0.2 | – | – |
19 | 4, F | 50; 3 | 4 | 46 | 49 | 0.5 | 1.4 | 11.5, SC | – |
20 | 5, M | 50; 30 | 4 | 49 | 79 | 0.1 | 0.3 | – | – |
21 | 5, M | 50; 24 | 5 | 54 | 78 | 1.1 | 5.7 | 10.0, SC | – |
22 | 4, F | 87.5e; 24 | 4 | 45 | 69 | 1.5 | 23.2 | – | – |
23 | 5, M | 50; 16 | 4 | 31 | 47 | 0.2 | 3.2 | – | – |
24 | 4, M | 87.5e; 16 | 4 | 35 | 51 | 0.1 | 1.8 | 11.7, O | – |
25 | 5, F | 50; 19 | N/A | N/A | N/A | 0.5 | 0.8 | 22.9, O | 0.1 |
26 | 5, F | 87.5e; 19 | N/A | N/A | N/A | 3.8 | 3.8 | 11.5, O | – |
27 | 5, M | 50; 19 | N/A | N/A | N/A | 0.6 | 3.3 | 20.1, O | 0.1 |
28 | 4, M | 87.5g; 21 | N/A | N/A | N/A | 0.5 | 0.5 | 14.8, O | – |
29 | 5, F | 87.5e; 10 | N/A | N/A | N/A | 8.0 | 12.5 | 12.2, O | – |